Page 163 - Read Online
P. 163
Yang et al. Hepatoma Res 2019;5:13 I http://dx.doi.org/10.20517/2394-5079.2019.04 Page 9 of 9
24. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with
percutaneous ablation therapies. Hepatology 2009;49:453-9.
25. Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgrò G, et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol
and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol 2010;52:380-8.
26. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, et al. Recurrent hepatocellular carcinoma treated with sequential transcatheter
arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012;262:689-700.
